Literature DB >> 34409999

Severe Acute Respiratory Syndrome Coronavirus 2 Variant Delta Infects All 6 Siblings but Spares Comirnaty (BNT162b2, BioNTech/Pfizer)-Vaccinated Parents.

Nadia Nathan1, Blandine Prevost1, Sidonie Lambert2,3, Aurélie Schnuriger3,4, Harriet Corvol1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34409999      PMCID： PMC8499735          DOI： 10.1093/infdis/jiab410

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.

Authors:  Jessica Taytard; Blandine Prevost; Aurélie Schnuriger; Guillaume Aubertin; Laura Berdah; Lauren Bitton; Audrey Dupond-Athenor; Guillaume Thouvenin; Nadia Nathan; Harriet Corvol
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

Review 2.  How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants.

Authors:  Ying Guo; Jun Meng; Caide Liu; Guosheng Chen; Yuhua Chi; Shiliang Zheng; Haixia Wang
Journal:  Front Public Health       Date:  2022-03-15

3.  Clinical Epidemiology of Pediatric COVID-19 Delta Variant Cases From North Sumatra, Indonesia.

Authors:  R Lia Kusumawati; Inke Nadia Diniyanti Lubis; Meutia Ayuputeri Kumaheri; Ariel Pradipta; Kiatichai Faksri; Mutiara Mutiara; Anuraj H Shankar; Tryna Tania
Journal:  Front Pediatr       Date:  2022-04-01       Impact factor: 3.418

4.  Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France.

Authors:  Blandine Prévost; Aurélia Retbi; Florence Binder-Foucard; Aurélie Borde; Amélie Bruandet; Harriet Corvol; Véronique Gilleron; Maggie Le Bourhis-Zaimi; Xavier Lenne; Joris Muller; Eric Ouattara; Fabienne Séguret; Pierre Tran Ba Loc; Sophie Tezenas du Montcel
Journal:  Front Pediatr       Date:  2022-09-07       Impact factor: 3.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.